Latest news and research on all cancers and treatments, updated several times a week
Old and poor 'get worse outcomes', report finds
National Audit Office accuse NHS of age discrimination of cancer patients
Finds patients from deprived background experience worst outcomes
Five year survival rates 10 per cent behind wealthy European nations
Report finds some 5,500 patients waited more than 62 days for treatment
Labour 'deeply disappointed' and 'shocked' by cancer survival rates
Patients twice as likely to die within a year if diagnosed with cancer at A&E
Their disease tends to be more advanced than those referred by GP
GPs have also been criticised in the National Audit Office report
Cancer of the pancreas is one of the most confounding diseases and rarely is caught at an early stage. Silent and lethal, only 7 percent of patients ...
Macrocystic adenocarcinoma of the pancreatic head. ... of a protein that plays an important role in in the progression of breast and pancreatic cancers.
The treatment failed in a Phase III trial against advanced pancreatic cancer back in 2012, but NantCell believes it can use genomics to find the ideal ...
Our products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections ...
... of cancer-associated antigens together with a potent immune adjuvant called "gp96" to educate and activate a cancer patient's immune system to ...
Adapted from Nourkeyhani H, George S. J Targeted Ther Cancer. ... response and are co-opted by tumors as a means to evade the immune system.
In a study published in Infectious Agents and Cancer journal, researchers found that ... white blood cells, which results in a stronger immune system.
... with non-small cell lung cancer as well as a Phase 2 with its vesigenurtacel-L (HS-410) in patients with non-muscle invasive bladder cancer.
This diverse group's mission: determining how Google[x] can boost the suddenly hot field of cancer immunotherapy, which enlists a body's own ...
MD Anderson has developed a novel approach to cancer immunotherapy, and Intrexon and Ziopharma have invested $100 million with the ...
Researchers at Roswell Park Cancer Institute have received a four-year, $11.9 million NYSTEM grant to advance an innovative immunotherapy ...
Cancer News in Science Daily
A protein widely known for suppressing tumor formation also helps prevent autoimmune diseases and other problems by putting the brakes on the immune response.
Researchers have uncovered how melanoma becomes resistant to a promising new drug combo therapy utilizing BRAF+MEK inhibitors in patients after an initial period of tumor shrinkage.
An unexpected observation has been made by a researcher while studying the locations inside cells where EGFR (epidermal growth factor receptor) can be found. His subsequent investigation revealed how some cancers evade clinical drugs: by sneaking through the cellular back door. Cancer cells are able to use the inactive EGFR form to thrive, the scientist reports.
For the first time, researchers have succeeded in amplifying genes altered by activities such as smoking -- with changes that can lead to lung cancer. As the amplified genes retain the altered information, this marks an important step towards quickly and efficiently localizing this type of genetic alteration and improving our ability to analyze causes of cancer.
New research helps explain why pancreatic cancer is so lethal, with fewer than a third of patients surviving even early stage disease. The researchers found a gene known to be involved in nearly 90 percent of pancreatic cancers promotes cancer growth and spread. The gene, ATDC, plays a key role in how a tumor progresses from a preinvasive state to an invasive cancer to metastatic cancer.
Cancer diagnosis and treatment decisions are often hampered by a lack of knowledge of the biological processes occurring within the tumor. Now researchers have developed a new approach to analyze these processes with a technique called proximity ligation assays (PLA). PLA allows specific protein complexes to be visualized and measured in cancer specimens. This may aid in patient treatment decisions in the future.
The genetic underpinnings of a rare type of breast tumor called phyllodes tumors have been characterized by researchers, offering the first comprehensive analysis of the molecular alterations at work in these tumors.
Tambahkan Komentar